SynthesisPloS one2018

Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer.

Mikyung Kelly Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.